Jefferies, BofA Securities, Leerink Partners, Guggenheim Securities, Truist Securities, et LifeSci Capital endossent le rôle de co-chefs de file de l’offre, Van Lanschot Kempen assurant celui de chef ...

MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (“MEDIROM” or the “Company”), today announced that on June 4, 2025, it received a written ...

Positive effects of ART26.12 were observed in a surgical rat model of osteoarthritis, in which either single or repeated oral doses of Artelo’s FABP5 inbitor increased the ability of rats to bear ...

About DIOSynVax DIOSynVax is a clinical-stage biotechnology company focused on developing universal vaccines using cutting-edge artificial intelligence technologies. The company's mission is to ...

Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the entry ...

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will ...

FREDERICK, Md., June 05, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today ...

ARLINGTON, Va., June 05, 2025 (GLOBE NEWSWIRE) -- Tria Federal has promoted Atchut Kanthamani to the new position of President. In this role, he will lead Tria's business growth and technology ...

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...

Doheny Eye Institute, one of the nation’s leading vision research institutions for more than 75 years, is adding to its panel of remarkable vision scientists with the appointment of Emma ...

SARASOTA, FL, June 05, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug ...

Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, announced that it has been selected for inclusion in the preliminary list of additions to the ...